Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 11681 - 11688 of 12007 results

Supreme Court to Hear Case re Employer's Access to Employee's Text Messages
December 16, 2009| Blog| Viewpoint

More Detail on Quan Case
December 16, 2009| Blog| Viewpoint

Holiday Privacy Watch: Take care before you donate that cell phone
December 8, 2009| Blog| Viewpoint

Court issues written opinion explaining decision regarding applicability of Red Flags Rule to attorneys
December 3, 2009| Blog| Viewpoint

The Other Duty to Accommodate: Employees' Religious Beliefs, Observances & Practices
November 24, 2009| Blog| Viewpoint

$1.8 Million Verdict in Pretexting Case
October 29, 2009| Blog| Viewpoint

Sometimes, less really is more ... and more is just too darn much!
October 15, 2009| Blog| Viewpoint

ADEA Plaintiffs Must Show that Age was a Determinative "But For" Reason for Adverse Employment Action, But For How Long?
October 14, 2009| Blog| Viewpoint
News & Press Releases
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Mintz represented S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans and energy, in its $40 million Series B financing of Sojo Industries, an industrial automation company that utilizes robotics, mobility, and software to deliver packaging and assembly solutions to the food and beverage industry.
Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|

Health Law Diagnosed: PBM Update Spring 2025
June 10, 2025| Podcast|
